Prevalence of anti–platelet factor 4/polyanionic antibodies after COVID‐19 vaccination with ChAdOx1 nCoV‐19 and CoronaVac in Thais
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Article activity feed
-
-
SciScore for 10.1101/2021.07.15.21260622: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics Consent: All participants gave written informed consent.
IRB: The study protocol was approved by the Human Research Ethics Committee of the Faculty of Medicine at Ramathibodi Hospital, Mahidol University.Sex as a biological variable not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Table 2: Resources
Antibodies Sentences Resources Anti-PF4/polyanionic antibodies were screened by IgG-specific ELISA (Hyphen Biomed Zymutest HIA IgG, Quadratech Diagnostics, UK) according to the manufacturer’s instructions. Anti-PF4/polyanionicsuggested: NoneSoftware and Algorithms Sentences Resources All statical analyses were performed on GraphPad Prism 9.1.1 (GraphPad Software, CA, … SciScore for 10.1101/2021.07.15.21260622: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics Consent: All participants gave written informed consent.
IRB: The study protocol was approved by the Human Research Ethics Committee of the Faculty of Medicine at Ramathibodi Hospital, Mahidol University.Sex as a biological variable not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Table 2: Resources
Antibodies Sentences Resources Anti-PF4/polyanionic antibodies were screened by IgG-specific ELISA (Hyphen Biomed Zymutest HIA IgG, Quadratech Diagnostics, UK) according to the manufacturer’s instructions. Anti-PF4/polyanionicsuggested: NoneSoftware and Algorithms Sentences Resources All statical analyses were performed on GraphPad Prism 9.1.1 (GraphPad Software, CA, USA) and Stata statistical software version 15.1 (StataCorp, TX, 2018). GraphPad Prismsuggested: (GraphPad Prism, RRID:SCR_002798)GraphPadsuggested: (GraphPad Prism, RRID:SCR_002798)Stata statisticalsuggested: NoneStataCorpsuggested: (Stata, RRID:SCR_012763)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
Results from scite Reference Check: We found no unreliable references.
-